Related Experiment Video
Updated: Jan 2, 2026
05:46
Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
725
Pharmacological Strategies for Presbyopia Correction
Journal of Refractive Surgery (Thorofare, N.J. : 1995)
|December 13, 2019
Summary
Pharmacological eye drops show promise for correcting presbyopia by improving near vision through pupillary miosis. Further research is needed to confirm effectiveness and understand limitations for this vision condition.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Presbyopia, an age-related condition, causes difficulty with near vision.
- Current correction methods include reading glasses and refractive surgery.
- Pharmacological interventions are being explored as a novel treatment approach.
Purpose of the Study:
- To review and summarize current pharmacological strategies for presbyopia correction.
- To evaluate the potential of drug-induced pupillary miosis and accommodation restoration.
Main Methods:
- Literature review focusing on pharmacologically induced pupillary miosis.
- Analysis of studies investigating lens softening and other accommodative measures.
Main Results:
- Pharmacological miosis can improve near vision temporarily with minimal impact on distance vision.
- Potential adverse effects on low-light vision (mesopic and scotopic) require further investigation.
- Evidence for drug-induced restoration of true accommodation is currently lacking.
Conclusions:
- Pharmacological eye drops may offer a future solution for presbyopia.
- More research is essential to establish the efficacy and safety of these treatments.
- Understanding the precise mechanisms and limitations is crucial for clinical application.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
907
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
907
01:16Focusing of Light in the Eye
5.1K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
5.1K
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.2K
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.7K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.7K